Primary treatment of a combined somatotropin- and thyrotropin-secreting pituitary tumour with octreotide.
Walsh
J P
JP
Glatthaar
C
C
Pullan
P T
PT
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D013972:Thyrotropin / Q000378:metabolism*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D013972:Thyrotropin; D013006:Growth Hormone; D015282:Octreotide